Status:
UNKNOWN
MS Detection of Somatic Mutations in Hematological Malignancies
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Hematological Malignancy
Eligibility:
All Genders
18+ years
Brief Summary
Detection of somatic mutations in hematological malignancies is now routinely assessed by NGS sequencing. This powerful approach is nevertheless time consuming and its costs represent limitation for i...
Eligibility Criteria
Inclusion
- adults \>18 years old
- anonymized samples already studied with NGS in Strasbourg university hematology center for somatic mutations
- non-opposition of the patient for testing the archive sample with the new method
Exclusion
- opposition for testing the archive sample with the new method
- insufficient archival material
- patient under protection
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03771079
Start Date
December 1 2018
End Date
December 1 2019
Last Update
December 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire d'Hématologie
Strasbourg, France, 67098